论文部分内容阅读
目的:研究米索前列醇预防剖宫产术后出血的临床效果。方法:以我院妇产科所收治的52例剖宫产孕妇纳入本研究,根据随机数字表法将其均分为对照组与观察组各26例,对照组常规给予催产素以预防产后出血,观察组则给予催产素、米索前列醇联合预防术后出血,分别在观察两组出血情况,并对研究结果相关数据作统计学处理。结果:与对照组相比,观察组产后出血量以及出血率更低,组间差异显著而具有统计学意义(P<0.05);与用药前相比,观察组患者用药后舒张压与收缩压并无较大波动,前后差异并无统计学意义(P>0.05)。结论:在应用缩宫素的基础上联合米索前列醇可有效预防剖宫产患者术后出血,值得临床推广应用。
Objective: To study the clinical effect of misoprostol in preventing bleeding after cesarean section. Methods: Fifty-two pregnant women with cesarean section admitted to our department of obstetrics and gynecology were enrolled in this study. According to the random number table, they were equally divided into control group and observation group with 26 cases each. The control group was given oxytocin routinely to prevent postpartum hemorrhage , The observation group was given oxytocin, misoprostol combined to prevent postoperative bleeding, were observed in two groups of bleeding, and the results of the data for statistical analysis. Results: Compared with the control group, the observation group postpartum hemorrhage and bleeding rate was lower, the difference between the groups was significant and statistically significant (P <0.05); compared with before treatment, the observation group after treatment of patients with diastolic blood pressure and systolic blood pressure There was no significant fluctuation, with no significant difference before and after (P> 0.05). Conclusion: The combination of oxytocin and misoprostol can effectively prevent postoperative bleeding in cesarean section patients, which is worthy of clinical application.